Bisphosphonate-related osteonecrosis of the jaws: A report of three cases demonstrating variability in outcomes and morbidity

Journal of the American Dental Association

Volumn 138, Issue 5, 2007, Pages 602-609

  Kumar, Vandana ^a   Pass, Barry ^b   Guttenberg, Steven A ^c,d   Ludlow, John ^a   Emery, Robert W ^c,d   Tyndall, Donald A ^a   Padilla, Ricordo J ^e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HOWARD UNIVERSITY   (United States)

^c Washington Hospital Center ^*

^d WASHINGTON HOSPITAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Angiogenesis; Bisphosphonates; Chemotherapy; Cone beam volumetric computed tomography; Hypercalcemia; Multiple myeloma; Osteonecrosis; Osteoporosis; Panoramic radiography

Indexed keywords

EID: 34249684415     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0230     Document Type: Article

References (18)

1. Hortobagyi GN. Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol 2002;29(3 supplement 11):134-44.
2. Cacace E, Ruggiero V, Matulli C, Uras L, Perpignano G. Markers of bone resorption in bisphosphonate therapy of Paget's disease. Clin Exp Rheumatol 2004;22(4):502.
3. Nase JB, Suzuki JB. Osteonecrosis of the jaw and oral bisphosphonate treatment. JADA 2006;137(8):1115-9.
4. Speiser PW, Clarson CL, Eugster EA, et al. Bisphosphonate treatment of pediatric bone disease. Pediatr Endocrinol Rev 2005;3(2): 87-96.
5. van Persijn van Meerten EL, Kroon HM, Papapoulos SE. Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology 1992;184(1):249-54.
6. Schwartz HC. Osteonecrosis of the jaws: a complication of cancer chemotherapy. Head Neck Surg 1982;4(3):251-3.
7. Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bisphossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005;63(5):682-9.
8. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(4):433-41.
9. Leite AF, Figueiredo PT, Melo NS, et al. Bisphosphonate-associated osteonecrosis of the jaws: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(1):14-21.
10. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper (published correction appears in JADA 2006;137([1]):26.). JADA 2005;136(12):1658-68.
11. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 2006;35(4):236-43.
12. Scarfe WC, Farman AG, Sukovic P. Clinical applications of cone-beam computed tomography in dental practice. J Can Dent Assoc 2006;72(1):75-80.
13. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63(11):1567-75.
14. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62(5):527-34.
15. Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002;62(22):6538-44.
16. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302(3):1055-61.
17. Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. LDA J 2005;64(3):21-4.
18. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. JADA 2006;137(8):1144-50.